home / stock / imux / imux quote
Last: | $ |
---|---|
Change Percent: | 2.18% |
Open: | $8.72 |
Close: | $8.91 |
High: | $8.9799 |
Low: | $8.5022 |
Volume: | 4,415 |
Last Trade Date Time: | 02/12/2020 04:41:22 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $8.72 | $8.91 | $8.9799 | $8.5022 | 4,415 | 02-12-2020 |
$ | $8.9028 | $8.72 | $8.95 | $8.44 | 6,229 | 02-11-2020 |
$ | $8.5146 | $8.92 | $8.92 | $8.5146 | 9,197 | 02-10-2020 |
$ | $8.80 | $8.85 | $9.05 | $8.65 | 24,540 | 02-07-2020 |
$ | $9.18 | $8.87 | $9.18 | $8.70 | 18,481 | 02-06-2020 |
$ | $9.29 | $8.94 | $9.50 | $8.8663 | 5,224 | 02-05-2020 |
$ | $9.37 | $9.17 | $9.37 | $8.227 | 57,075 | 02-04-2020 |
$ | $8.96 | $8.96 | $8.96 | $8.189 | 21,970 | 02-03-2020 |
$ | $8.30 | $8.33 | $8.5195 | $8.08 | 24,716 | 01-31-2020 |
$ | $8.21 | $8.35 | $8.53 | $8.1249 | 19,657 | 01-30-2020 |
$ | $8.73 | $8.12 | $8.98 | $8.12 | 7,110 | 01-29-2020 |
$ | $8.12 | $8.67 | $8.76 | $8.12 | 6,806 | 01-28-2020 |
$ | $8.28 | $8.03 | $8.73 | $8.03 | 7,883 | 01-27-2020 |
$ | $8.79 | $8.215 | $8.932 | $8.15 | 25,046 | 01-24-2020 |
$ | $9.15 | $8.61 | $9.20 | $8.61 | 13,648 | 01-23-2020 |
$ | $9.22 | $9.04 | $9.46 | $8.61 | 50,733 | 01-22-2020 |
$ | $9.56 | $9.34 | $9.7399 | $9.13 | 26,063 | 01-21-2020 |
$ | $9.81 | $9.53 | $9.90 | $9.41 | 56,222 | 01-20-2020 |
$ | $9.81 | $9.53 | $9.90 | $9.41 | 56,221 | 01-17-2020 |
$ | $9.49 | $9.80 | $9.80 | $9.49 | 20,514 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
Immunic Inc. Company Name:
IMUX Stock Symbol:
NYSE Market:
Immunic to Host MS R&D Day and Participate in Investor Conferences in April Immunic to Host MS R&D Day and Participate in Investor Conferences in April PR Newswire NEW YORK , April 4, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a b...
--News Direct-- Immunic Inc (NASDAQ:IMUX) Chief Medical Officer Dr Andreas Muehler discusses the complexities of multiple sclerosis (MS) during an interview with Proactive's Stephen Gunnion to mark MS Awareness Month, highlighting the disease's impact, development, and the unmet medical n...
--News Direct-- Immunic Inc CEO Dr Daniel Vitt joins Proactive's Stephen Gunnion with news the company has received a Notice of Allowance from the US Patent and Trademark Office for a new patent application, marking a significant step in the company's intellectual property (IP) strategy. ...